Feb 15
|
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts
|
Feb 14
|
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
|
Feb 14
|
DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins
|
Feb 14
|
DexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin Challenges
|
Feb 14
|
DexCom (DXCM) Q4 2024 Earnings Call Transcript
|
Feb 13
|
Informatica CEO on earnings, top trading themes: Asking for a Trend
|
Feb 13
|
Here's What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings
|
Feb 13
|
GameStop, Twilio, DexCom: After-hours movers
|
Feb 13
|
DexCom (DXCM) Misses Q4 Earnings Estimates
|
Feb 13
|
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
|
Feb 13
|
DexCom: Q4 Earnings Snapshot
|
Feb 13
|
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
|
Feb 12
|
Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?
|
Feb 12
|
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
|
Feb 12
|
Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
|
Feb 11
|
DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?
|
Feb 10
|
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
|
Jan 4
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
|
Jan 2
|
Abbott, Dexcom settle glucose monitor patent lawsuits
|
Jan 1
|
The 5 worst performing stocks on the Nasdaq 100 in 2024
|